Simulations Plus EBITDA Margin 2012-2026 | SLP

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Simulations Plus (SLP) over the last 10 years. The current EBITDA margin for Simulations Plus as of February 28, 2026 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Simulations Plus EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-11-30 $0.08B $-0.06B -81.82%
2025-08-31 $0.08B $-0.06B -80.77%
2025-05-31 $0.08B $-0.06B -80.00%
2025-02-28 $0.08B $0.01B 13.92%
2024-11-30 $0.08B $0.01B 14.67%
2024-08-31 $0.07B $0.01B 15.49%
2024-05-31 $0.07B $0.01B 14.71%
2024-02-29 $0.07B $0.01B 18.46%
2023-11-30 $0.06B $0.01B 19.05%
2023-08-31 $0.06B $0.01B 20.00%
2023-05-31 $0.06B $0.01B 25.00%
2023-02-28 $0.06B $0.02B 27.27%
2022-11-30 $0.05B $0.02B 31.48%
2022-08-31 $0.05B $0.02B 37.04%
2022-05-31 $0.05B $0.02B 38.46%
2022-02-28 $0.05B $0.02B 40.00%
2021-11-30 $0.05B $0.02B 37.50%
2021-08-31 $0.05B $0.02B 38.30%
2021-05-31 $0.05B $0.02B 40.43%
2021-02-28 $0.05B $0.02B 39.13%
2020-11-30 $0.04B $0.02B 39.53%
2020-08-31 $0.04B $0.02B 36.59%
2020-05-31 $0.04B $0.02B 38.46%
2020-02-29 $0.04B $0.02B 40.54%
2019-11-30 $0.04B $0.01B 40.00%
2019-08-31 $0.03B $0.01B 41.18%
2019-05-31 $0.03B $0.01B 42.42%
2019-02-28 $0.03B $0.01B 40.63%
2018-11-30 $0.03B $0.01B 41.94%
2018-08-31 $0.03B $0.01B 43.33%
2018-05-31 $0.03B $0.01B 41.38%
2018-02-28 $0.03B $0.01B 44.44%
2017-11-30 $0.03B $0.01B 42.31%
2017-08-31 $0.02B $0.01B 41.67%
2017-05-31 $0.02B $0.01B 40.91%
2017-02-28 $0.02B $0.01B 38.10%
2016-11-30 $0.02B $0.01B 40.00%
2016-08-31 $0.02B $0.01B 40.00%
2016-05-31 $0.02B $0.01B 40.00%
2016-02-29 $0.02B $0.01B 40.00%
2015-11-30 $0.02B $0.01B 40.00%
2015-08-31 $0.02B $0.01B 36.84%
2015-05-31 $0.02B $0.01B 41.18%
2015-02-28 $0.02B $0.01B 40.00%
2014-11-30 $0.01B $0.01B 38.46%
2014-08-31 $0.01B $0.01B 41.67%
2014-05-31 $0.01B $0.00B 33.33%
2014-02-28 $0.01B $0.00B 36.36%
2013-11-30 $0.01B $0.01B 45.45%
2013-08-31 $0.01B $0.01B 50.00%
2013-05-31 $0.01B $0.01B 50.00%
2013-02-28 $0.01B $0.00B 40.00%
2012-11-30 $0.01B $0.00B 30.00%
2012-08-31 $0.01B $0.00B 30.00%
2012-05-31 $0.01B $0.00B 40.00%
2012-02-29 $0.01B $0.00B 40.00%
2011-11-30 $0.01B $0.00B 40.00%
2011-08-31 $0.01B $0.00B 40.00%
2011-05-31 $0.01B $0.00B 30.00%
2011-02-28 $0.01B $0.00B 30.00%
2010-11-30 $0.01B $0.00B 30.00%
2010-08-31 $0.01B $0.00B 30.00%
2010-05-31 $0.01B $0.00B 30.00%
2010-02-28 $0.01B $0.00B 30.00%
2009-11-30 $0.01B $0.00B 33.33%
2009-08-31 $0.01B $0.00B 33.33%
2009-05-31 $0.01B $0.01B 55.56%
2009-02-28 $0.01B $0.01B 55.56%
2008-11-30 $0.01B $0.01B 55.56%
2008-08-31 $0.01B $0.01B 66.67%
2008-05-31 $0.01B $0.01B 55.56%
2008-02-29 $0.01B $0.01B 55.56%
2007-11-30 $0.01B $0.01B 50.00%
2007-08-31 $0.01B $0.00B 33.33%
2007-05-31 $0.01B $0.00B 22.22%
2007-02-28 $0.01B $0.00B 25.00%
2006-11-30 $0.01B $0.00B 16.67%
2006-08-31 $0.01B $0.00B 16.67%
2006-05-31 $0.01B $0.00B 20.00%
2006-02-28 $0.00B 0 0.00%
2005-11-30 $0.00B 0 0.00%
2005-08-31 $0.00B 0 0.00%
2005-05-31 $0.00B $0.00B 25.00%
2005-02-28 $0.00B $0.00B 25.00%
2004-11-30 $0.00B $0.00B 25.00%
2004-08-31 $0.00B $0.00B 25.00%
2004-05-31 $0.01B $0.00B 20.00%
2004-02-29 $0.01B $0.00B 20.00%
2003-11-30 $0.01B $0.00B 20.00%
2003-08-31 $0.01B $0.00B 20.00%
2003-05-31 $0.00B 0 0.00%
2003-02-28 $0.00B 0 0.00%
2002-11-30 $0.00B 0 0.00%
2002-08-31 $0.00B 0 0.00%
2002-05-31 $0.00B 0 0.00%
2002-02-28 $0.00B 0 0.00%
2001-11-30 $0.00B 0 0.00%
2001-08-31 $0.00B 0 0.00%
2001-05-31 $0.00B 0 0.00%
2001-02-28 $0.00B 0 0.00%
2000-11-30 $0.00B 0 0.00%
2000-08-31 $0.00B 0 0.00%
2000-05-31 $0.00B 0 0.00%
2000-02-29 $0.00B 0 0.00%
1999-11-30 $0.00B 0 0.00%
1999-08-31 $0.00B 0 0.00%
1999-05-31 $0.00B $0.00B -25.00%
1999-02-28 $0.00B $0.00B -25.00%
1998-11-30 $0.00B $0.00B -50.00%
Sector Industry Market Cap Revenue
Computer and Technology Computer Software $0.263B $0.079B
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
Stock Name Country Market Cap PE Ratio
Microsoft (MSFT) United States $2753.943B 24.11
Oracle (ORCL) United States $397.153B 23.29
SAP SE (SAP) Germany $200.369B 23.43
Intuit (INTU) United States $97.052B 20.83
Adobe (ADBE) United States $91.086B 12.68
Synopsys (SNPS) United States $75.138B 41.38
Cadence Design Systems (CDNS) United States $73.347B 48.30
Dassault Systemes SA (DASTY) France $26.551B 15.11
SS&C Technologies Holdings (SSNC) United States $16.192B 12.48
PTC (PTC) United States $15.879B 17.91
Manhattan Associates (MANH) United States $7.161B 34.05
Pegasystems (PEGA) United States $6.655B 28.74
Descartes Systems Group (DSGX) Canada $5.426B 33.91
Open Text (OTEX) Canada $5.117B 5.65
Trend Micro (TMICY) Japan $4.192B 18.33
ACI Worldwide (ACIW) United States $4.058B 17.19
CommVault Systems (CVLT) United States $3.908B 37.98
Sapiens (SPNS) Israel $2.433B 31.04
Blackbaud (BLKB) United States $1.574B 12.02
PROS Holdings (PRO) United States $1.123B 0.00
Progress Software (PRGS) United States $1.121B 5.56
Rand Worldwide (RWWI) United States $0.506B 0.00
OptimizeRx (OPRX) United States $0.115B 9.15
NetSol Technologies (NTWK) United States $0.040B 21.06
Neonode (NEON) Sweden $0.024B 0.00
Smith Micro Software (SMSI) United States $0.018B 0.00
Wetouch Technology (WETH) China $0.016B 2.21
Global Interactive Technologies (GITS) South Korea $0.009B 0.00
Magic Software Enterprises (MGIC) Israel $0.000B 18.90